Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial

IF 21.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of the American College of Cardiology Pub Date : 2025-03-24 DOI:10.1016/j.jacc.2025.01.028
David J. Maron MD , Jonathan D. Newman MD, MPH , Rebecca Anthopolos DrPH , Ying Lu MS , Susanna Stevens MS , William E. Boden MD , Kreton Mavromatis MD , Jason Linefsky MD , Rajesh G. Nair MD, DM , Olga Bockeria MD, PhD , Gilbert Gosselin MD , Gian P. Perna MD , Elena Demchenko MD, PhD , David Foo MD , Michael D. Shapiro DO, MCR , Mary Ann Champagne CNS , Christie Ballantyne MD , Peter McCullough MD , Jose Luis Lopez-Sendon MD , Frank Rockhold PhD , Judith S. Hochman MD
{"title":"Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial","authors":"David J. Maron MD ,&nbsp;Jonathan D. Newman MD, MPH ,&nbsp;Rebecca Anthopolos DrPH ,&nbsp;Ying Lu MS ,&nbsp;Susanna Stevens MS ,&nbsp;William E. Boden MD ,&nbsp;Kreton Mavromatis MD ,&nbsp;Jason Linefsky MD ,&nbsp;Rajesh G. Nair MD, DM ,&nbsp;Olga Bockeria MD, PhD ,&nbsp;Gilbert Gosselin MD ,&nbsp;Gian P. Perna MD ,&nbsp;Elena Demchenko MD, PhD ,&nbsp;David Foo MD ,&nbsp;Michael D. Shapiro DO, MCR ,&nbsp;Mary Ann Champagne CNS ,&nbsp;Christie Ballantyne MD ,&nbsp;Peter McCullough MD ,&nbsp;Jose Luis Lopez-Sendon MD ,&nbsp;Frank Rockhold PhD ,&nbsp;Judith S. Hochman MD","doi":"10.1016/j.jacc.2025.01.028","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Guideline-directed medical therapy (GDMT) with multiple risk factor goals is recommended for patients with chronic coronary disease (CCD), yet achieving all GDMT goals is uncommon. The relative importance of these goals and timing of their attainment on cardiovascular events is uncertain.</div></div><div><h3>Objectives</h3><div>This study aims to describe the relationship between achieving specific GDMT goals, when they are achieved, and clinical outcomes.</div></div><div><h3>Methods</h3><div>This was an observational study of participants with CCD in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. The primary outcome was cardiovascular (CV) death or myocardial infarction (MI). GDMT goals were systolic blood pressure (SBP) &lt;130 mm Hg, low-density lipoprotein cholesterol &lt;70 mg/dL, not smoking, and antiplatelet therapy. Frequency of GDMT goals met at baseline and during follow-up is described. Bayesian joint modeling for longitudinal goal status and time-to-event analyses characterized the relative importance of specific GDMT goal attainment and timing with CV death/MI.</div></div><div><h3>Results</h3><div>All 5,179 ISCHEMIA participants were included. Among 4,914 participants with complete data on all 4 GDMT goals at baseline, 386 (9%), 2,073 (42%), 1,843 (38%), and 612 (12%) met 0-1, 2, 3, and 4 GDMT goals, respectively. The 4-year cumulative event rate for CV death/MI was highest for participants who attained no GDMT goals (24.5%; 95% credible interval [CrI]: 13.5%-42.2%) and lowest for those who attained all goals at baseline and remained at goal during follow-up (8.7%; 95% CrI: 6.7%-10.9%). SBP goal attainment was associated with a significant absolute event reduction in CV death/MI (–5.1%; 95% CrI: –11.3% to –1.0%), followed by antiplatelet therapy (–11.2%; 95% CrI: –29.1% to 0.8%), achieving low-density lipoprotein cholesterol &lt;70 mg/dL (–2.0%; 95% CrI: –6.0% to 2.4%), and not smoking (–1.7%; 95% CrI: –9.3% to 4.2%). Ten millimeters of mercury lower SBP during follow-up was associated with 10% relative risk reduction of CV death/MI (RR [relative risk] = 0.90; 95% CrI: 0.82-0.98), after adjusting for other GDMT goals and baseline characteristics.</div></div><div><h3>Conclusions</h3><div>Among participants with CCD, early attainment and maintenance of GDMT goals, especially SBP, were associated with fewer cardiovascular events. Compared with no GDMT goals at target, having all 4 GDMT goals at target at baseline was associated with an absolute 16% fewer CV deaths and MIs. (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; <span><span>NCT01471522</span><svg><path></path></svg></span>)</div></div>","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"85 12","pages":"Pages 1317-1331"},"PeriodicalIF":21.7000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0735109725003213","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Guideline-directed medical therapy (GDMT) with multiple risk factor goals is recommended for patients with chronic coronary disease (CCD), yet achieving all GDMT goals is uncommon. The relative importance of these goals and timing of their attainment on cardiovascular events is uncertain.

Objectives

This study aims to describe the relationship between achieving specific GDMT goals, when they are achieved, and clinical outcomes.

Methods

This was an observational study of participants with CCD in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. The primary outcome was cardiovascular (CV) death or myocardial infarction (MI). GDMT goals were systolic blood pressure (SBP) <130 mm Hg, low-density lipoprotein cholesterol <70 mg/dL, not smoking, and antiplatelet therapy. Frequency of GDMT goals met at baseline and during follow-up is described. Bayesian joint modeling for longitudinal goal status and time-to-event analyses characterized the relative importance of specific GDMT goal attainment and timing with CV death/MI.

Results

All 5,179 ISCHEMIA participants were included. Among 4,914 participants with complete data on all 4 GDMT goals at baseline, 386 (9%), 2,073 (42%), 1,843 (38%), and 612 (12%) met 0-1, 2, 3, and 4 GDMT goals, respectively. The 4-year cumulative event rate for CV death/MI was highest for participants who attained no GDMT goals (24.5%; 95% credible interval [CrI]: 13.5%-42.2%) and lowest for those who attained all goals at baseline and remained at goal during follow-up (8.7%; 95% CrI: 6.7%-10.9%). SBP goal attainment was associated with a significant absolute event reduction in CV death/MI (–5.1%; 95% CrI: –11.3% to –1.0%), followed by antiplatelet therapy (–11.2%; 95% CrI: –29.1% to 0.8%), achieving low-density lipoprotein cholesterol <70 mg/dL (–2.0%; 95% CrI: –6.0% to 2.4%), and not smoking (–1.7%; 95% CrI: –9.3% to 4.2%). Ten millimeters of mercury lower SBP during follow-up was associated with 10% relative risk reduction of CV death/MI (RR [relative risk] = 0.90; 95% CrI: 0.82-0.98), after adjusting for other GDMT goals and baseline characteristics.

Conclusions

Among participants with CCD, early attainment and maintenance of GDMT goals, especially SBP, were associated with fewer cardiovascular events. Compared with no GDMT goals at target, having all 4 GDMT goals at target at baseline was associated with an absolute 16% fewer CV deaths and MIs. (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; NCT01471522)

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
42.70
自引率
3.30%
发文量
5097
审稿时长
2-4 weeks
期刊介绍: The Journal of the American College of Cardiology (JACC) publishes peer-reviewed articles highlighting all aspects of cardiovascular disease, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers and viewpoints. Content Profile: -Original Investigations -JACC State-of-the-Art Reviews -JACC Review Topics of the Week -Guidelines & Clinical Documents -JACC Guideline Comparisons -JACC Scientific Expert Panels -Cardiovascular Medicine & Society -Editorial Comments (accompanying every Original Investigation) -Research Letters -Fellows-in-Training/Early Career Professional Pages -Editor’s Pages from the Editor-in-Chief or other invited thought leaders
期刊最新文献
MORTALITY TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION AND CARDIOMYOPATHY: INSIGHTS FROM THE CDC WONDER DATABASE MAVACAMTEN-LIKE CARDIAC MYOSIN INHIBITOR MYK-581 REDUCES RISK OF ATRIAL FIBRILLATION INDUCTION IN MURINE MODEL OF HYPERTROPHIC CARDIOMYOPATHY THERAPEUTIC EFFECT OF INTRACORONARY CARDIOSPHERE-DERIVED CELL SECRETOME ON VENTRICULAR TACHYCARDIA INDUCIBILITY AND CARDIAC FUNCTION IN AN EXPERIMENTAL MYOCARDIAL INFARCTION MODEL INITIAL IMPACT OF 2022 MEDICARE REIMBURSEMENT CUTS ON ATRIAL FIBRILLATION ABLATION UTILIZATION COMPARATIVE OUTCOMES OF EARLY VERSUS DELAYED RESUMPTION OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION OR ATRIAL FLUTTER AFTER NON-MAJOR INTRACRANIAL HEMORRHAGE: A POPULATION-BASED COHORT STUDY
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1